The success of recommendations to improve screening often rests on the availability of efficacious therapies, coverage policies, and other factors that enable and justify screening. Objectives: To ...

A hepatitis panel is a blood test that doctors use to diagnose hepatitis. Hepatitis refers to a group of viral liver diseases, including hepatitis A, hepatitis B, and hepatitis C. The blood test will ...

Hepatitis C virus (HCV) has contributed to more US patient deaths than the next 60 reportable infectious diseases combined. The United States Preventive Services Task Force has issued updated ...

Routine and rapid hepatitis C virus testing among young adults who use injection drugs improves life expectancy and may provide a good use of limited resources, according to new research. Routine and ...

Hepatitis C virus (HCV) screening is recommended for patients at risk and/or born during 1945–1965, but screening gaps persist. This new program screens target populations and enhances care linkage ...

When people seek help at a drug treatment center for an opioid addiction, concerns about having contracted hepatitis C are generally low on their list. They’ve often reached a crisis point in their ...

Hepatitis C infection rates have exploded in the United States, more than tripling over the past decade. Because of this, routine screening for hepatitis C -- which can destroy the liver over time -- ...

The U.S. Preventive Services Task Force (USPSTF) now recommends the hepatitis C virus (HCV) infection screening for adults in the age group 18 to 79 years. This update comes against the background of ...

The US Preventive Services Task Force now recommends screening for hepatitis C infection in all adults ages 18 to 79 without known liver disease, regardless of their risk. This updated recommendation, ...

Public health experts warn any delay to the newborn dose of the hepatitis B vaccine could threaten decades of progress.